MedTrace Logo

Efficacy and Safety of Intravenous Fosfomycin in Prosthetic Joint Infection

NCT03260010 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 224

Last updated 2018-04-19

No results posted yet for this study

Summary

The PROOF Study is an open prospective interventional non-randomized study which aim is to determine the outcome / effect and safety of fosfomycin in patients with hip, knee or shoulder PJI.

Conditions

  • Prosthetic Joint Infection

Interventions

DRUG

Fosfomycin

Infectofos 5 g

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    collaborator OTHER

  • Pro-Implant Foundation

    lead OTHER

Principal Investigators

  • Andrej Trampuz, PD Dr. · Charité - Univeristätsmedizin

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-15
Primary Completion
2020-04-15
Completion
2021-04-15

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03260010 on ClinicalTrials.gov